Liposome formulation of NSC-639829 using halothane as a solvent: a technical note.
Jain
Akash
A
College of Pharmacy, The University of Arizona, Tucson AZ 85721, USA. akash.jain@pharmacy.arizona.edu
Sanghvi
Tapan
T
Yalkowsky
Samuel H
SH
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D016503:Drug Delivery Systems; D006221:Halothane / Q000737:chemistry*; D008081:Liposomes / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012997:Solvents; D014508:Urea / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes; C434925:N-4-((5-bromo-2-pyrimidoxy)-3-methylphenyl)-(2-dimethylamino)benzoylurea; D011743:Pyrimidines; D012997:Solvents; D014508:Urea; D006221:Halothane